Replies to post #256450 on Biotech Values

[DewDiligence]

ALKS raises AVDL buyout offer_to $21/sh cash +CVR:

https://www.reuters.com/business/healthcare-pharmaceuticals/alkermes-raises-offer-avadel-after-lundbeck-bid-2025-11-19/

Avadel's board said it now favors Alkermes' improved bid over Lundbeck's proposal. While both offers include the same $21-per-share upfront cash payment, Avadel said Alkermes' contingent payment terms were more likely to be met. The board called Lundbeck's milestone-based payments "unlikely to be achieved."